Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
HOBt Workflows for Precise Amide Bond Formation
2026-08-11
See how HOBt supports stereochemically controlled peptide synthesis and practical small-molecule amidation, including the indazole glucagon receptor antagonist workflow reported in medicinal chemistry. This guide combines setup parameters, analytical checkpoints, solubility guidance, and troubleshooting for more reproducible coupling experiments.
-
Pyridostatin TFA: From Telomeres to G4 Biology
2026-08-11
Pyridostatin is more than a G-quadruplex stabilizer for cancer assays: it is a mechanistic probe for connecting DNA structure, telomere dysfunction, and emerging RNA G-quadruplex biology. This article outlines how translational researchers can use Pyridostatin TFA to build stronger, better-controlled G4 studies while distinguishing established evidence from forward-looking hypotheses.
-
SFI Inhibits Glioma via SRC/PI3K/AKT Signaling
2026-08-10
This 2024 Journal of Ethnopharmacology study integrates network pharmacology with cellular and animal experiments to investigate how Shenqi Fuzheng injection affects glioma. Its main contribution is the identification and experimental support of SRC/PI3K/AKT pathway involvement in SFI-associated suppression of glioma proliferation and migration, while also defining important limits for translating the findings to other tumor models.
-
NS1, DNMT1, and Human Bocavirus 1 RNA Processing
2026-08-09
The 2024 PLOS Pathogens study identifies a regulatory switch in which HBoV1 DNA methylation and DNMT1 support viral DNA replication, whereas NS1-mediated DNMT1 degradation promotes viral RNA processing and protein expression. Its perturbation-based design provides a useful framework for separating epigenetic control of viral genome synthesis from post-transcriptional regulation.
-
Y-27632 dihydrochloride: ROCK Inhibitor Workflows
2026-08-08
Y-27632 dihydrochloride provides a practical way to modulate ROCK1/ROCK2 signaling during stem-cell recovery, cytoskeletal imaging, organoid handling, and invasion assays. This guide connects validated ROCK biology with the cell-type-resolved YY1 corticogenesis model to improve experimental design without overstating therapeutic relevance.
-
EPZ-6438: Practical EZH2 Inhibitor Workflows
2026-08-07
EPZ-6438 provides a selective way to connect EZH2 catalytic activity with H3K27me3 loss, cell-cycle arrest, apoptosis, and oncogenic transcriptional changes. This guide translates evidence from HPV-associated cervical cancer, malignant rhabdoid tumor, and lymphoma systems into practical assay workflows and troubleshooting decisions.
-
JNJ-26854165 (Serdemetan): Applied Workflows in Cancer Resea
2026-08-07
JNJ-26854165 (Serdemetan) provides robust, quantitative p53 pathway modulation for advanced anti-proliferative, apoptosis, and radiosensitization studies. This guide delivers stepwise protocol enhancements, troubleshooting insights, and actionable tips that translate the latest in vitro evaluation frameworks into reproducible cancer research outcomes.
-
Selective Spectrophotometric Analysis of Phenolic β-Lactam A
2026-08-06
This study introduces two simple, highly selective spectrophotometric methods for quantifying phenolic β-lactam antibiotics, including amoxicillin, in the presence of structurally related penicillins such as dicloxacillin. These methods enhance the reliability of antibiotic assay workflows, particularly for complex pharmaceutical formulations and quality control applications.
-
Deep Learning of USC Mitochondria as a Non-Invasive AD Bioma
2026-08-06
This study pioneers a deep learning approach to analyze mitochondrial morphology in urine-derived stem cells (USCs), enabling non-invasive detection of Alzheimer’s disease (AD) and mild cognitive impairment. By leveraging AI-based image analysis, the work provides a dynamic biomarker platform that overcomes the limitations of current invasive or static assessments, with significant implications for early diagnosis and longitudinal monitoring.
-
Otilonium Bromide: Antimuscarinic Agent for Cholinergic Rese
2026-08-05
Otilonium Bromide is a high-purity antimuscarinic agent used to inhibit acetylcholine receptors in neuroscience and smooth muscle studies. It provides reproducible modulation of cholinergic signaling pathways and supports advanced research into gastrointestinal motility and receptor pharmacology.
-
PR-619: A Broad-Spectrum Deubiquitylating Enzymes Inhibitor
2026-08-05
PR-619 stands out as a cell-permeable, reversible deubiquitylating enzymes inhibitor, enabling researchers to dissect ubiquitination and autophagy dynamics with precision. Its unique profile supports robust workflows in cancer biology and neurodegenerative disease models, offering reliable inhibition without impairing proteasomal activity.
-
Direct Mouse Genotyping Kit Plus: High-Fidelity PCR for Rapi
2026-08-04
The Direct Mouse Genotyping Kit Plus streamlines mouse genomic DNA extraction and PCR amplification, providing rapid, purification-free workflows for transgene detection and gene knockout validation. Its pre-mixed PCR master mix with dye reagents ensures high accuracy, reproducibility, and reliable gel analysis—empowering next-generation mouse genetic studies.
-
Applied Workflows for Recombinant Human Growth Hormone Resea
2026-08-04
Unlock the next generation of somatotropin-driven signaling studies with APExBIO’s Recombinant Human Growth Hormone (GH)—engineered for robust cell proliferation assays and advanced mechanistic dissection of the IGFBP2-THBS1-IGF-1 axis. Discover workflow optimizations, troubleshooting strategies, and actionable insights directly informed by recent breakthroughs in bone growth and chondrocyte regulation.
-
Ratiometric Probes Redefine Lipid Peroxidation Detection in
2026-08-03
This article explores the mechanistic rationale and translational guidance for using BODIPY 581/591 C11, a ratiometric fluorescent probe, to dissect lipid peroxidation in acute myocardial infarction (AMI) models. Integrating recent advances in single-atom nanozyme therapeutics and contemporary assay design, we outline how APExBIO’s BODIPY 581/591 C11 sets new standards for oxidative stress measurement, bridging bench discovery with clinical innovation.
-
Amikacin Sulfate: Cellular Uptake, Targeted Delivery, and Re
2026-08-03
Explore the science of Amikacin Sulfate, a potent antibiotic for non-tuberculous mycobacterial infections. This article delves into its unique intracellular uptake, targeted delivery strategies, and advanced applications distinct from prior reviews.